"Yap"-ing about the Antifibrotic Benefits of Prostacyclin
- PMID: 30562049
- PMCID: PMC6913084
- DOI: 10.1165/rcmb.2018-0392ED
"Yap"-ing about the Antifibrotic Benefits of Prostacyclin
Comment on
-
The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ.Am J Respir Cell Mol Biol. 2019 May;60(5):578-591. doi: 10.1165/rcmb.2018-0142OC. Am J Respir Cell Mol Biol. 2019. PMID: 30537446
Similar articles
-
Multiple signalling options for prostacyclin.Acta Pharmacol Sin. 2003 Jul;24(7):625-30. Acta Pharmacol Sin. 2003. PMID: 12852825 Review.
-
The prostacyclin pathway in pulmonary arterial hypertension: a clinical review.Expert Rev Respir Med. 2017 Jun;11(6):491-503. doi: 10.1080/17476348.2017.1317599. Epub 2017 Apr 24. Expert Rev Respir Med. 2017. PMID: 28399721 Review.
-
Cardioprotective prostacyclin signaling in vascular smooth muscle.Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):109-18. doi: 10.1016/j.prostaglandins.2006.05.011. Epub 2006 Jul 7. Prostaglandins Other Lipid Mediat. 2007. PMID: 17164138 Review.
-
Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension?Am J Respir Cell Mol Biol. 2002 Feb;26(2):171-4. doi: 10.1165/ajrcmb.26.2.f230. Am J Respir Cell Mol Biol. 2002. PMID: 11804866 No abstract available.
-
Prostacyclin: A major prostaglandin in the regulation of adipose tissue development.J Cell Physiol. 2019 Apr;234(4):3254-3262. doi: 10.1002/jcp.26932. Epub 2018 Nov 15. J Cell Physiol. 2019. PMID: 30431153 Review.
Cited by
-
Update in Interstitial Lung Disease 2019.Am J Respir Crit Care Med. 2020 Aug 15;202(4):500-507. doi: 10.1164/rccm.202002-0360UP. Am J Respir Crit Care Med. 2020. PMID: 32412784 Free PMC article. Review. No abstract available.
References
-
- Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232–235. - PubMed
-
- Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters-Golden M. Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol. 2007;292:L405–L413. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources